According to a new report published by K D Market Insights, titled, “Pharmaceutical Excipients Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global pharmaceutical excipients market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The expanding pharmaceuticals market, the increasing demand for functional excipients, the surge in the generics market, the rising uptake of biopharmaceuticals, and the adoption of orphan drugs which are the major factors augmenting the growth of the global pharmaceutical excipients market.

The surge in the generics market plays a significant role. The rise in generic drug production and usage fuels the demand for pharmaceutical excipients is further expected to create ample growth opportunities for the global pharmaceutical excipients market during the forecast period i.e., 2023-2032. Moreover, the increasing demand for functionality excipients, is increasing has propelled market expansion. Nanotechnology enables the development of innovative drug delivery systems and formulations, which require specialized excipients, is expected to contribute towards the market growth during the period.

The Europe region accounted for the largest share in the global pharmaceutical excipients market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the presence of major pharmaceutical players and the growing demand for high-quality pharmaceutical products.

According to product type, the organic chemicals segment accounted for the largest market share in the pharmaceutical excipients market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global pharmaceutical excipients market is segmented into product type, functionality, formulations, end-users and region. Based on product type, the market is bifurcated into organic chemicals, inorganic chemicals, and others. Based on functionality, it is classified into fillers and diluents, suspension, and viscosity agents, coating agents, binders, disintegrants, colorants, lubricants and glidants, preservatives, emulsifying agents, flavoring agents and sweeteners, other functionalities. Based on formulations, it is classified into topical formulations, oral formulations, parenteral formulations, other formulations. Based on end-users, it is classified into pharmaceuticals companies, research organization, academics, others.

The global pharmaceutical excipients market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Pharmaceutical Excipients Market

• On the basis of product type, the organic chemicals segment accounted for the largest market share in the pharmaceutical excipients market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
• On the basis of region, Europe accounted for the largest share in the global pharmaceutical excipients market in 2022. The region is further projected to continue dominating in the market during the forecast period.
• On the basis of region, North America is estimated to account for the second largest share in the market during the forecast period.

Some of the major pharmaceutical excipient companies profiled in the report include Ashland Global Holdings, BASF SE, DuPont, Roquette Frères, Evonik Industries AG, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, and Kerry Group.

Related Reports :-

https://www.kdmarketinsights.com/reports/pain-therapeutics-market/5403

https://www.kdmarketinsights.com/reports/nonalcoholic-steatohepatitis-therapeutics-market/5402

https://www.kdmarketinsights.com/reports/sports-medicine-market/5401

https://www.kdmarketinsights.com/reports/surgical-booms-market/5396